To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

Clinical trial NCT02385318 · COMPLETED

Trial details

NCT number: NCT02385318
Sponsor: Padagis LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2015-02-01
Primary completion: 2015-12-01
Enrollment: 519

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.